These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30166208)

  • 21. Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.
    Wier HA; Cerna A; So TY
    Paediatr Drugs; 2011 Apr; 13(2):97-106. PubMed ID: 21351809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome.
    Grosso S; Coppola G; Cusmai R; Parisi P; Spalice A; Foligno S; Verrotti A; Balestri P
    Acta Neurol Scand; 2014 Jun; 129(6):420-4. PubMed ID: 24479878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: Final results from randomized study 303.
    Arzimanoglou A; Ferreira J; Satlin A; Olhaye O; Kumar D; Dhadda S; Bibbiani F
    Eur J Paediatr Neurol; 2019 Jan; 23(1):126-135. PubMed ID: 30309816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rufinamide efficacy and association with phenotype and genotype in children with intractable epilepsy: A retrospective single center study.
    Oesch G; Bozarth XL
    Epilepsy Res; 2020 Dec; 168():106211. PubMed ID: 31575436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
    Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K;
    Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of antiseizure medication for Lennox-Gastaut syndrome: a systematic review and network meta-analysis.
    Zhang L; Wang J; Wang C
    Dev Med Child Neurol; 2022 Mar; 64(3):305-313. PubMed ID: 34590711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.
    Coppola G; Besag F; Cusmai R; Dulac O; Kluger G; Moavero R; Nabbout R; Nikanorova M; Pisani F; Verrotti A; von Stülpnagel C; Curatolo P
    Eur J Paediatr Neurol; 2014 Nov; 18(6):685-90. PubMed ID: 24929673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive, adaptive, and behavioral effects of adjunctive rufinamide in Lennox-Gastaut syndrome: A prospective observational clinical study.
    Operto FF; Verrotti A; Marrelli A; Ciuffini R; Coppola G; Pastorino GMG; Striano P; Sole M; Zucca C; Manfredi V; Città S; Elia M
    Epilepsy Behav; 2020 Nov; 112():107445. PubMed ID: 32920379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating Lennox-Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide.
    Gresham J; Eiland LS; Chung AM
    Neuropsychiatr Dis Treat; 2010 Oct; 6():639-45. PubMed ID: 20957124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness and safety of rufinamide at treatment of epilepsy with complications and drug-resistant epilepsy (according to meta-analysis data)].
    Mazin PV; Sheshunov IV; Kislitsyn YV; Mazina NK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):40-43. PubMed ID: 27635610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: the first Italian prospective study.
    Moavero R; Cusmai R; Specchio N; Fusco L; Capuano A; Curatolo P; Vigevano F
    Epilepsy Res; 2012 Nov; 102(1-2):94-9. PubMed ID: 22677424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox-Gastaut syndrome (ELEKTRA).
    Hahn CD; Jiang Y; Villanueva V; Zolnowska M; Arkilo D; Hsiao S; Asgharnejad M; Dlugos D
    Epilepsia; 2022 Oct; 63(10):2671-2683. PubMed ID: 35841234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined surgical intervention with vagus nerve stimulation following corpus callosotomy in patients with Lennox-Gastaut syndrome.
    Katagiri M; Iida K; Kagawa K; Hashizume A; Ishikawa N; Hanaya R; Arita K; Kurisu K
    Acta Neurochir (Wien); 2016 May; 158(5):1005-12. PubMed ID: 26979179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of rufinamide in childhood refractory epilepsy.
    Yıldız EP; Hızlı Z; Bektaş G; Ulak-Özkan M; Tatlı B; Aydınlı N; Çalışkan M; Özmen M
    Turk J Pediatr; 2018; 60(3):238-243. PubMed ID: 30511535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of rufinamide in children under four years of age with drug-resistant epilepsies.
    Grosso S; Coppola G; Dontin SD; Gobbi G; Pruna D; Accorsi P; Verrotti A; Parisi P; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):641-5. PubMed ID: 24912730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy).
    Kluger G; Bauer B
    Neuropsychiatr Dis Treat; 2007 Feb; 3(1):3-11. PubMed ID: 19300535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulthiame add-on therapy in children with Lennox-Gastaut syndrome: A study of 44 patients.
    Caraballo RH; Flesler S; Reyes Valenzuela G; Fortini S; Chacón S; Ross L; Noli D
    Seizure; 2018 Nov; 62():55-58. PubMed ID: 30286409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rufinamide for the treatment of Lennox-Gastaut syndrome.
    Besag FM
    Expert Opin Pharmacother; 2011 Apr; 12(5):801-6. PubMed ID: 21348771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.